Overview
Johannes Eckhardt advises private equity and venture capital funds as well as strategic investors on transactions in the healthcare, life sciences and technology sectors.
He supports financial sponsor clients throughout the investment lifecycle, including acquisitions, divestitures, investments and portfolio matters. His experience includes a wide range of transaction types such as leveraged buyouts, growth investments, joint ventures, and carve-out deals.
Johannes has particular experience in the health services and life sciences industries, with a strong understanding of the regulatory landscape and commercial drivers shaping these sectors.
Prior to joining McDermott Will & Schulte, he worked in-house at Merck KGaA, Darmstadt, Germany gaining valuable insights into the operational and legal challenges on the corporate side.
Results
Johannes advised:
- Insight Partners on various investments in German companies and related transactions including HelloFresh (IPO), Delivery Hero (IPO), HomeToGo (De-SPAC), commercetools and N26*
- Hudson’s Bay Company on formation of department store joint venture and real estate joint ventures with Signa involving Galeria Kaufhof and Karstadt as well as subsequent sale of shares in joint ventures*
- EQT Mid Market Europe on the acquisition of BBS Automation*
- M Ventures, the strategic venture capital fund of Merck KGaA, on various biotech and tech investments all over the world as well as on several exit transactions including the sale of Calypso Biotech*
- Merck KGaA, Darmstadt, Germany on the acquisition of Mirus Bio (US) and various other transactions*
*Matter handled prior to joining the firm.
Credentials
Education
FernUniversität Hagen, Diploma in Economics, 2014
University of California, Berkeley, LL.M., 2013
Higher Regional Court of Frankfurt am Main, Second State Examination, 2011
Goethe University Frankfurt am Main, First State Examination, 2008
Admissions
Germany
New York
Languages
German
English
